Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (271-280 of 299) with videos related to

Pageof 30
Sort By:
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2F Xu, S A Leadon, Y Yu, et al.
American Journal of Obstetrics and Gynecology|August 1, 1988
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant diseaseG D Malkasian, R C Knapp, P T Lavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent mannerT Furui, R LaPushin, M Mao, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
Cancer|May 1, 1994
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerA S Lukes, M F Kohler, C F Pieper, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cell Death & Disease|August 7, 2015
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenograftsM N Washington, G Suh, A F Orozco, et al.
Pageof 30

Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2F Xu, S A Leadon, Y Yu, et al.
American Journal of Obstetrics and Gynecology|August 1, 1988
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant diseaseG D Malkasian, R C Knapp, P T Lavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent mannerT Furui, R LaPushin, M Mao, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
Cancer|May 1, 1994
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerA S Lukes, M F Kohler, C F Pieper, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cell Death & Disease|August 7, 2015
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenograftsM N Washington, G Suh, A F Orozco, et al.
Pageof 30